SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000902664-22-004631
Filing Date
2022-10-24
Accepted
2022-10-24 16:57:31
Documents
1

Document Format Files

Seq Description Document Type Size
1 PIERIS PHARMACEUTICALS, INC. p22-2335sc13g.htm SC 13G 66699
  Complete submission text file 0000902664-22-004631.txt   68341
Mailing Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109
Business Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Subject) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88917 | Film No.: 221326466
SIC: 2834 Pharmaceutical Preparations

Mailing Address 151 CALLE DE SAN FRANCISCO SUITE 200 PMB 1237 SAN JUAN PR 00901-1607
Business Address 151 CALLE DE SAN FRANCISCO SUITE 200 PMB 1237 SAN JUAN PR 00901-1607 703-963-7214
Lynx1 Capital Management LP (Filed by) CIK: 0001910456 (see all company filings)

IRS No.: 851134656 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G